Responses
Clinical and epidemiological research
Concise report
A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis
Compose a Response to This Article
Other responses
No responses have been published for this article.